Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

APM

Aptorum (APM)

Aptorum Group Ltd
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:APM
日付受信時刻ニュースソース見出しコード企業名
2024/04/3022 : 15Business WireAptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business UpdateNASDAQ:APMAptorum Group Ltd
2024/03/0622 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
2024/03/0622 : 00Business WireAptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy BusinessNASDAQ:APMAptorum Group Ltd
2023/12/2306 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
2023/12/2306 : 30Business WireAptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023NASDAQ:APMAptorum Group Ltd
2023/12/2206 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
2023/12/2206 : 30Business WireAptorum Group Limited Announces Results of 2023 Annual General Meeting of ShareholdersNASDAQ:APMAptorum Group Ltd
2023/12/0106 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
2023/11/2200 : 25Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:APMAptorum Group Ltd
2023/11/1701 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
2023/11/1701 : 00Business WireAptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023NASDAQ:APMAptorum Group Ltd
2023/09/1205 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
2023/08/1019 : 07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
2023/08/1015 : 57Business WireAptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital MarketsNASDAQ:APMAptorum Group Ltd
2023/07/1505 : 30Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:APMAptorum Group Ltd
2023/07/0105 : 31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
2023/07/0105 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
2023/06/2221 : 00Business WireAptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for NeuroblastomaNASDAQ:APMAptorum Group Ltd
2023/06/1005 : 31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
2023/06/1005 : 30Business WireAptorum Group Limited Announces Voluntary Delisting from Euronext ParisNASDAQ:APMAptorum Group Ltd
2023/05/2422 : 01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APMAptorum Group Ltd
2023/05/2219 : 02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APMAptorum Group Ltd
2023/05/1805 : 31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:APMAptorum Group Ltd
2023/05/0822 : 00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
2023/05/0605 : 31Business WireAptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity DeficiencyNASDAQ:APMAptorum Group Ltd
2023/05/0322 : 29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APMAptorum Group Ltd
2023/05/0121 : 00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
2023/05/0121 : 00Business WireAptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations LimitedNASDAQ:APMAptorum Group Ltd
2023/04/2822 : 44Business WireAptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business UpdateNASDAQ:APMAptorum Group Ltd
2023/04/2822 : 19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
 Showing the most relevant articles for your search:NASDAQ:APM